tiprankstipranks
Trending News
More News >
Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
India Market

Mankind Pharma Ltd. (MANKIND) Financial Statements

Compare
11 Followers

Mankind Pharma Ltd. Financial Overview

Mankind Pharma Ltd.'s market cap is currently ₹908.07B. The company's EPS TTM is ₹12.4; its P/E ratio is 51.56; and it has a dividend yield of 0.04%. Mankind Pharma Ltd. is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is ₹12.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 122.07B₹ 103.35B₹ 87.43B₹ 77.82B₹ 62.14B
Gross Profit₹ 87.18B₹ 70.14B₹ 33.88B₹ 53.12B₹ 43.89B
Operating Income₹ 60.26B₹ 40.87B₹ 16.18B₹ 18.61B₹ 16.06B
EBITDA₹ 30.18B₹ 28.09B₹ 20.27B₹ 21.47B₹ 18.17B
Net Income₹ 19.91B₹ 19.13B₹ 12.82B₹ 14.33B₹ 12.65B
Balance Sheet
Cash & Short-Term Investments₹ 22.45B₹ 34.56B₹ 15.29B₹ 12.79B₹ 20.04B
Total Assets₹ 277.60B₹ 119.63B₹ 97.15B₹ 91.48B₹ 63.73B
Total Debt₹ 85.11B₹ 2.07B₹ 1.70B₹ 8.73B₹ 2.41B
Net Debt₹ 79.57B₹ -1.75B₹ -1.34B₹ 5.71B₹ 734.77M
Total Liabilities₹ 131.91B₹ 23.87B₹ 20.67B₹ 28.31B₹ 15.10B
Stockholders' Equity₹ 143.32B₹ 93.63B₹ 74.35B₹ 61.55B₹ 47.22B
Cash Flow
Free Cash Flow₹ 19.53B₹ 17.70B₹ 9.53B₹ -14.26B₹ 8.25B
Operating Cash Flow₹ 24.13B₹ 21.52B₹ 17.85B₹ 9.20B₹ 11.37B
Investing Cash Flow₹ -126.92B₹ -20.82B₹ -10.54B₹ -13.69B₹ -12.22B
Financing Cash Flow₹ 102.33B₹ 52.66M₹ -7.40B₹ 6.05B₹ -78.11M
Currency in INR

Mankind Pharma Ltd. Earnings and Revenue History

Mankind Pharma Ltd. Debt to Assets

Mankind Pharma Ltd. Cash Flow

Mankind Pharma Ltd. Forecast EPS vs Actual EPS